BIOMAT Database Logo BIOMAT Database Logo

Fluconazole-resistant oral candidosis in HIV-infected patients. 1995

P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela

UI MeSH Term Description Entries
D002180 Candidiasis, Oral Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed) Moniliasis, Oral,Thrush,Candidiases, Oral,Moniliases, Oral,Oral Candidiases,Oral Candidiasis,Oral Moniliases,Oral Moniliasis
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Fluconazole resistant oral candidiasis in HIV-infected patients.
May 1997, Oral diseases,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Oral candidosis in HIV-infected patients.
November 2008, Current HIV research,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Oral candidosis in HIV-infected patients.
September 1990, British journal of clinical practice. Supplement,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Fluconazole-resistant candidosis in an HIV cohort.
June 1994, AIDS (London, England),
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
March 1998, AIDS (London, England),
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient.
January 1994, Mycoses,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
January 1995, The Journal of antimicrobial chemotherapy,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
August 2002, Pharmacological research,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
[Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
January 1996, Annales de dermatologie et de venereologie,
P Diz Dios, and A Ocampo Hermida, and C Miralles Alvarez, and I Iglesias Martin, and I Otero Varela
Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
February 1996, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!